The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effects of emerin dysregulation on the very-small-nuclear phenotype and neuronal differentiation and its association with a clinically aggressive subtype of prostate cancer.
 
Le Zhang
No Relationships to Disclose
 
Pai-Chi Teng
No Relationships to Disclose
 
Karen Cavassani
No Relationships to Disclose
 
Catherine Grasso
No Relationships to Disclose
 
Joshua Watson
No Relationships to Disclose
 
Jasmine Wang
No Relationships to Disclose
 
Zijing Chen
No Relationships to Disclose
 
Kai Tu
No Relationships to Disclose
 
Brenda Salumbides
No Relationships to Disclose
 
Lilit Gevorkian
No Relationships to Disclose
 
Minhyung Kim
No Relationships to Disclose
 
Sungyong You
No Relationships to Disclose
 
Dolores Di Vizio
No Relationships to Disclose
 
Howard Sandler
Consulting or Advisory Role - Janssen
Other Relationship - Caribou Publishing
 
Timothy Daskivich
No Relationships to Disclose
 
Neil Bhowmick
No Relationships to Disclose
 
Michael Freeman
No Relationships to Disclose
 
Hsian-Rong Tseng
No Relationships to Disclose
 
Jie-Fu Chen
No Relationships to Disclose
 
Edwin Posadas
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer
Research Funding - PFizer (Inst)
Patents, Royalties, Other Intellectual Property - Patent on NanoVelcro Assay for CTCs in prostate cancer
Expert Testimony - Shook, Hardy & Bacon L.L.P.